Epiminder Ltd (EPI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Epiminder Ltd (EPI) has a cash flow conversion efficiency ratio of -0.342x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-34.30 Million ≈ $-24.27 Million USD) by net assets (AU$100.27 Million ≈ $70.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View Epiminder Ltd stock quote for real-time trading data and today's change.
Epiminder Ltd - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Epiminder Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Epiminder Ltd market capitalisation for the company's overall valuation and market capitalisation.
Epiminder Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Epiminder Ltd ranked by their cash flow conversion efficiency. Also see EPI total asset value for a full breakdown of the balance sheet.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dekeloil Public Ltd
LSE:DKL
|
-0.452x |
|
Bumrungrad Hospital Public Company Limited
F:BZ7A
|
0.067x |
|
VOLTAGE METALS CORP.
F:8L10
|
0.036x |
|
MyHealthChecked Plc
LSE:MHC
|
-0.067x |
|
Selina Hospitality PLC
NASDAQ:SLNAF
|
-0.016x |
|
Bangkok Bank Public Company Limited
F:BKKF
|
0.014x |
|
Sporttotal AG
F:WIG1
|
0.078x |
|
Fletcher King Plc
LSE:FLK
|
-0.091x |
Annual Cash Flow Conversion Efficiency for Epiminder Ltd (2023–2025)
The table below shows the annual cash flow conversion efficiency of Epiminder Ltd from 2023 to 2025. Review EPI financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$107.39 Million ≈ $75.98 Million |
AU$-16.98 Million ≈ $-12.01 Million |
-0.158x | -108.95% |
| 2024-06-30 | AU$-7.79 Million ≈ $-5.51 Million |
AU$-13.77 Million ≈ $-9.74 Million |
1.767x | +117.26% |
| 2023-06-30 | AU$1.39 Million ≈ $984.74K |
AU$-14.25 Million ≈ $-10.08 Million |
-10.239x | -- |
About Epiminder Ltd
Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company's Minder system comprises Minder implant, a sub scalp electrode with mul… Read more